BridgeBio, BMS Set Sail In Expanded SHP2 Collaboration

 
• By Alaric DeArment
  
BridgeBio and BMS announced an expansion to their partnership to develop SHP2 inhibitor BBP-398 • Source: Shutterstock

More from Anticancer

More from Therapy Areas